KUCHARCHUK ANDREW ALBERT 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
KUCHARCHUK ANDREW ALBERT
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-07+1,162,099→ 1,162,099 totalExercise: $0.06From: 2026-01-07Exp: 2036-01-06→ Common Stock (1,162,099 underlying)